Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,544 | -8,470 | -6,727 | -4,562 | -1,700 |
| Depreciation Amortization | 49 | 220 | 174 | 143 | 70 |
| Accounts receivable | 10 | 24 | 3 | -25 | N/A |
| Accounts payable and accrued liabilities | -58 | 389 | 55 | 134 | N/A |
| Other Working Capital | -672 | -970 | -269 | 72 | -50 |
| Other Operating Activity | 75 | 287 | 599 | 489 | 70 |
| Operating Cash Flow | $-3,139 | $-8,520 | $-6,166 | $-3,750 | $-1,610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -280 | -128 | -85 | -30 |
| Purchase Of Investment | N/A | -2,001 | -2,000 | -2,000 | N/A |
| Sale Of Investment | N/A | 1,436 | 1,485 | 1,487 | N/A |
| Purchase Sale Intangibles | -19 | -99 | -90 | -49 | N/A |
| Other Investing Activity | -19 | -96 | -90 | -49 | 1,110 |
| Investing Cash Flow | $-57 | $-940 | $-733 | $-646 | $1,080 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 13,638 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -8 | 13,636 | 13,628 | 2,350 |
| Financing Cash Flow | $N/A | $13,630 | $13,636 | $13,628 | $2,350 |
| Beginning Cash Position | 6,909 | 2,740 | 2,747 | 2,747 | 2,740 |
| End Cash Position | 3,713 | 6,900 | 9,484 | 11,978 | 4,570 |
| Net Cash Flow | $-3,196 | $4,160 | $6,737 | $9,232 | $1,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,139 | -8,520 | -6,166 | -3,750 | -1,610 |
| Capital Expenditure | -39 | -284 | -128 | -85 | N/A |
| Free Cash Flow | -3,178 | -8,804 | -6,294 | -3,835 | -1,610 |